@article{fiets_multigene_2004,
	title = {A multigene {RT}-{PCR} assay used to predict recurrence in early breast cancer: two presentations with contradictory results},
	volume = {6},
	issn = {1465-5411},
	shorttitle = {A multigene {RT}-{PCR} assay used to predict recurrence in early breast cancer},
	url = {http://www.ncbi.nlm.nih.gov/pmc/articles/PMC549172/},
	doi = {10.1186/bcr911},
	abstract = {During the 2003 San Antonio Breast Cancer Symposium two studies were presented that were designed to validate a recurrence score, derived from a 21-gene RT-PCR assay, in patients with axillary node-negative breast cancer. This recurrence score was highly predictive for the risk of recurrence in 668 patients treated in a large multicenter trial with adjuvant tamoxifen. However, no prognostic value was found in a small group of patients who were retrospectively selected in a single institution and who did not receive any adjuvant systemic therapy. Further validation is needed to establish the prognostic and predictive role of this assay in clinical management.},
	number = {5},
	urldate = {2013-04-21},
	journal = {Breast Cancer Research},
	author = {Fiets, Willem E and Nortier, Johan WR},
	year = {2004},
	pmid = {15318922},
	pmcid = {PMC549172},
	pages = {185--187},
	file = {PubMed Central Full Text PDF:files/38460/Fiets and Nortier - 2004 - A multigene RT-PCR assay used to predict recurrenc.pdf:application/pdf}
}

{"_id":"rFjNypQ9MGeSo58u5","bibbaseid":"fiets-nortier-amultigenertpcrassayusedtopredictrecurrenceinearlybreastcancertwopresentationswithcontradictoryresults-2004","downloads":0,"creationDate":"2016-09-09T06:27:31.833Z","title":"A multigene RT-PCR assay used to predict recurrence in early breast cancer: two presentations with contradictory results","author_short":["Fiets, W. E","Nortier, J. W."],"year":2004,"bibtype":"article","biburl":"https://www.sfu.ca/~howlett/howlett16.bib","bibdata":{"bibtype":"article","type":"article","title":"A multigene RT-PCR assay used to predict recurrence in early breast cancer: two presentations with contradictory results","volume":"6","issn":"1465-5411","shorttitle":"A multigene RT-PCR assay used to predict recurrence in early breast cancer","url":"http://www.ncbi.nlm.nih.gov/pmc/articles/PMC549172/","doi":"10.1186/bcr911","abstract":"During the 2003 San Antonio Breast Cancer Symposium two studies were presented that were designed to validate a recurrence score, derived from a 21-gene RT-PCR assay, in patients with axillary node-negative breast cancer. This recurrence score was highly predictive for the risk of recurrence in 668 patients treated in a large multicenter trial with adjuvant tamoxifen. However, no prognostic value was found in a small group of patients who were retrospectively selected in a single institution and who did not receive any adjuvant systemic therapy. Further validation is needed to establish the prognostic and predictive role of this assay in clinical management.","number":"5","urldate":"2013-04-21","journal":"Breast Cancer Research","author":[{"propositions":[],"lastnames":["Fiets"],"firstnames":["Willem","E"],"suffixes":[]},{"propositions":[],"lastnames":["Nortier"],"firstnames":["Johan","WR"],"suffixes":[]}],"year":"2004","pmid":"15318922","pmcid":"PMC549172","pages":"185--187","file":"PubMed Central Full Text PDF:files/38460/Fiets and Nortier - 2004 - A multigene RT-PCR assay used to predict recurrenc.pdf:application/pdf","bibtex":"@article{fiets_multigene_2004,\n\ttitle = {A multigene {RT}-{PCR} assay used to predict recurrence in early breast cancer: two presentations with contradictory results},\n\tvolume = {6},\n\tissn = {1465-5411},\n\tshorttitle = {A multigene {RT}-{PCR} assay used to predict recurrence in early breast cancer},\n\turl = {http://www.ncbi.nlm.nih.gov/pmc/articles/PMC549172/},\n\tdoi = {10.1186/bcr911},\n\tabstract = {During the 2003 San Antonio Breast Cancer Symposium two studies were presented that were designed to validate a recurrence score, derived from a 21-gene RT-PCR assay, in patients with axillary node-negative breast cancer. This recurrence score was highly predictive for the risk of recurrence in 668 patients treated in a large multicenter trial with adjuvant tamoxifen. However, no prognostic value was found in a small group of patients who were retrospectively selected in a single institution and who did not receive any adjuvant systemic therapy. Further validation is needed to establish the prognostic and predictive role of this assay in clinical management.},\n\tnumber = {5},\n\turldate = {2013-04-21},\n\tjournal = {Breast Cancer Research},\n\tauthor = {Fiets, Willem E and Nortier, Johan WR},\n\tyear = {2004},\n\tpmid = {15318922},\n\tpmcid = {PMC549172},\n\tpages = {185--187},\n\tfile = {PubMed Central Full Text PDF:files/38460/Fiets and Nortier - 2004 - A multigene RT-PCR assay used to predict recurrenc.pdf:application/pdf}\n}\n\n","author_short":["Fiets, W. E","Nortier, J. W."],"key":"fiets_multigene_2004","id":"fiets_multigene_2004","bibbaseid":"fiets-nortier-amultigenertpcrassayusedtopredictrecurrenceinearlybreastcancertwopresentationswithcontradictoryresults-2004","role":"author","urls":{"Paper":"http://www.ncbi.nlm.nih.gov/pmc/articles/PMC549172/"},"downloads":0},"search_terms":["multigene","pcr","assay","used","predict","recurrence","early","breast","cancer","two","presentations","contradictory","results","fiets","nortier"],"keywords":[],"authorIDs":[],"dataSources":["Bn7xRaKMY43f7hFwh"]}